IndoNutriQA: An Indonesian Clinical Nutrition Question Answering Benchmark

cs.CL Tirana Noor Fatyanosa, Ummu Ditya Erliana, Mahendra Data, Muhammad Nurwegiono, Eleazar Tadeo Eman, Alham Fikri Aji · Oct 22, 2026
Local to this browser
What it does
Clinical question answering in Indonesian is hampered by a complete lack of public, domain-specific data. IndoNutriQA introduces 911 expert-authored, abstractive question–answer pairs grounded in real clinical-nutrition reports, using...
Why it matters
IndoNutriQA introduces 911 expert-authored, abstractive question–answer pairs grounded in real clinical-nutrition reports, using eight standardized questions from the Nutrition Care Process to create a controlled evaluation benchmark. Its...
Main concern
IndoNutriQA is a carefully scoped and ethically curated benchmark that fills a genuine gap in Indonesian clinical NLP. Its strengths include transparent acknowledgment of single-annotator limitations, a multi-metric evaluation suite with...
Community signal
0
0 up · 0 down
Sign in to vote with arrows
AI Review AI reviewed
Plain-language introduction

Clinical question answering in Indonesian is hampered by a complete lack of public, domain-specific data. IndoNutriQA introduces 911 expert-authored, abstractive question–answer pairs grounded in real clinical-nutrition reports, using eight standardized questions from the Nutrition Care Process to create a controlled evaluation benchmark. Its rigorous validation protocol and public release aim to advance low-resource clinical NLP and nutrition-focused decision support.

Critical review
Verdict
Bottom line

IndoNutriQA is a carefully scoped and ethically curated benchmark that fills a genuine gap in Indonesian clinical NLP. Its strengths include transparent acknowledgment of single-annotator limitations, a multi-metric evaluation suite with bootstrap confidence intervals, and a candid LLM-judge calibration study. However, the paper contains a verifiable factual error in its related-work comparison: it claims PubMedQA has 11K expert-labelled instances, whereas the original source reports only 1K expert-annotated cases out of 273K total. Together with a modest scale ($n=137$ test split), a narrow fixed-question scope, and unvalidated safety scores, this limits the paper's authority as a definitive reference, though it remains a valuable evaluation resource.

“PubMedQA [Jin et al. (2019)] derives yes/no/maybe labels from abstract conclusions, only 11K of its 273K instances being expert-labelled;”
IndoNutriQA paper · Section 2
“PubMedQA has 1k expert-annotated, 61.2k unlabeled and 211.3k artificially generated QA instances.”
“judge-vs-rater agreement approaches the inter-rater ceiling on factuality (0.705 vs 0.780) and completeness (0.623 vs 0.752) but collapses on clinical safety (0.133)”
IndoNutriQA paper · Section 6.5
What holds up

The dataset construction is admirably transparent: the authors voluntarily adopt HIPAA Safe Harbor de-identification, release structured metadata, and honestly report that each reference answer has only one nutritionist author. Their statistical protocol goes beyond typical benchmark papers, adding 5-fold cross-validation stratified by source report, learning curves, and bootstrap CIs to a small test split. Most impressively, the LLM-as-judge calibration against three expert raters and the subsequent human error analysis directly advance the methodology of clinical NLP evaluation: they show that an LLM judge tracks human factuality well but misses unsupported clinical additions that humans catch, and they report this without spin.

“judge-vs-rater agreement approaches the inter-rater ceiling on factuality (0.705 vs 0.780) and completeness (0.623 vs 0.752) but collapses on clinical safety (0.133)”
IndoNutriQA paper · Section 6.5
“the raters flagged unsupported added content in 55 units (10%10\%) that the judge's hallucination label did not flag”
IndoNutriQA paper · Section 6.8
Main concerns

The single-annotator design is a hard ceiling: the authors plainly note that a conventional inter-annotator $\kappa$ over the references is undefined, and they estimate that 6–10% of audited reference answers are contestable. The fixed eight-question NCP/PES protocol, while enabling controlled comparison, deliberately excludes open-ended clinical dialogue and leaves whole sections of the source reports untested. A verifiable citation error in the related work—claiming PubMedQA has 11K expert-labelled instances versus the actual 1K—undermines confidence in the dataset literature review.

On the modeling side, the fine-tuned baselines are uncompetitive: mT5 achieves essentially zero exact match and plateauing near-zero F1 even with more data, and the RAG system collapses because the mt5-base generator fails. This reinforces the authors' position that the corpus is an evaluation benchmark, not a training set, but it also means the paper provides almost no evidence about how a stronger Indonesian generative model would perform. Finally, the LLM judge's safety dimension is admitted to be unvalidated ($\kappa=0.133$ with raters), and the self-preference test is underpowered, so claims about clinical safety should be treated with caution.

“single-annotator pairs do not guarantee a unique gold answer per question, particularly for the recommendation-style questions”
IndoNutriQA paper · Limitations
“mT5 plateaus near zero across all fractions, indicating its bottleneck is architectural, not data”
IndoNutriQA paper · Appendix B
Evidence and comparison

The positioning table (Table 7) offers a fair and useful comparison across language, domain, answer type, and source, correctly distinguishing IndoNutriQA from exam-based and template-generated corpora. Stratified analysis by disease category also supports generalization claims: the top 5-shot LLM performs within a narrow F1 band across represented categories. Yet the held-out test split entirely omits cardiac and renal/urologic reports, so the benchmark cannot verify performance on those conditions. The cross-lingual transfer claim—that English medical pretraining helps more than Indonesian general-domain pretraining—is supported by MedGemma-4B-IT's strong results but is explicitly admitted to rest on only two English-medical models, one of which (BioMistral-7B) does not follow the pattern, making the evidence suggestive rather than conclusive.

“the held-out test split is not stratified by disease category: it over-represents neurologic (20.0% vs. 10.0% of the corpus) and hematologic/oncologic (15.0% vs. 8.3%) while under-representing infectious (5.0% vs. 17.5%), and contains no cardiac or renal/urologic reports at all”
IndoNutriQA paper · Limitations
“The evidence is limited, however: it rests on two English-medical models, and BioMistral-7B (29.83) does not follow the pattern.”
IndoNutriQA paper · Section 6.3
Reproducibility

Data release is exemplary: the authors publish the anonymized dataset, evaluation scripts, and cached LLM predictions under open licenses, which removes the need to re-query paid APIs to reproduce tables. However, the main paper and appendices lack critical implementation details for the fine-tuned and RAG baselines. Exact training hyperparameters—batch size, learning rate, number of epochs, optimizer settings—are not stated for the IndoBERT or mT5 runs, and the RAG configuration is described only as 'a single dense retriever over recursive chunks feeding an un-fine-tuned mt5-base generator,' leaving chunk size, overlap, retriever model, and top-k unspecified. An independent researcher could approximate these experiments, but true reproduction would require additional correspondence with the authors.

“The anonymized IndoNutriQA dataset and the full evaluation pipeline (including the prediction caches needed to reproduce every table and figure in this paper without re-querying LLM APIs) are publicly released”
IndoNutriQA paper · Data and Code Availability
“a single dense retriever over recursive chunks feeding an un-fine-tuned mt5-base generator”
IndoNutriQA paper · Appendix D
Abstract

Clinical Question Answering (QA) underpins Clinical Intelligent Decision Support Systems, but progress is severely limited for low-resource languages such as Indonesian by the absence of public domain-specific data. We introduce IndoNutriQA, an expert-curated Indonesian clinical QA benchmark of 911 question-answer pairs built from real clinical-nutrition reports. Rather than a large-scale training corpus, it is positioned as a high-quality evaluation resource: every pair is grounded in a clinically relevant context, enriched with structured metadata (anthropometric assessment, medical diagnosis, document provenance, chunk segmentation). Eight standardised question types following the Nutrition Care Process (NCP), including the Problem, Etiology, Sign and Symptom (PES) diagnosis statement, are answered for every report, which was written by a graduate-level dietetic intern, by one of three nutritionists. Answers are free-form clinical prose rather than extractive spans, and an expert validation study finds 6-10% of reference answers contestable. The dataset supports generative, extractive and retrieval-augmented QA as well as zero- and few-shot LLM evaluation. We report fine-tuned baselines (IndoBERT variants, mT5, RAG) with 5-fold cross-validation, learning curves and bootstrap 95% confidence intervals, and benchmark eight contemporary LLMs zero- and five-shot. We further calibrate our LLM-as-judge rubric against three expert raters (one RD, two nutritionists), finding it human-comparable on factuality and completeness but unreliable on clinical safety, and a human error analysis shows it misses unsupported content that the raters identify. IndoNutriQA is released to foster research in Indonesian clinical NLP and nutritional decision support.

Challenge the Review

Pick a starting point or write your own. Challenges run in the background, so you can keep reading while the AI investigates.

No challenges yet. Disagree with the review? Ask the AI to revisit a specific claim.